The number of applications for invention patents continues to grow in Taiwan. In 2022, 50,242 invention patents were filed in Taiwan, an increase of 2.3% due to surging growth between 9.4-16.1% in applications from the US, Mainland China and Korea. On the other hand, WIPO accepted approx. 278,100 PCT applications, marking the slowest increase of 0.3% in 13 years since 2009.
For more information, Please visit:
2022 Trends & Comparisons: Taiwan Invention Patent Applications and WIPO PCT Applications
TIPO has released the English version of the “Patent Examination Guidelines, Part II: Substantive Examination for Invention Patents, Chapter 1. Written Description, Claim, Abstract and Drawing” to enhance the international IP community’s understanding of Taiwan’s patent examination process. Moreover, it functions as a helpful tool for foreign applicants, enabling them to assess whether their patent applications meet the requirements specified in said Guidelines.
For more information, Please visit:
TIPO Publishes English Version of Patent Examination Guidelines, Part II, Chapter 1
TIPO previously required applicants seeking to extend patent terms on pharmaceutical products or manufacturing methods to submit documentation for the duration of all domestic and/or international clinical trials. Documentation was then sent to the Food and Drug Administration (FDA) of the Ministry of Health and Welfare (MOHW), the central competent authority, to confirm the clinical trial period required for issuing a drug license.
For more information, Please visit:
Amendment to the Regulations Governing the Determination of Patent Term Extention Come into Effect on July 1, 2023
Draft revisions to the Enforcement Rules of the Patent Act to meet patent examination needs and increase examination efficiency were promulgated on March 24, 2023. The revisions will take effect on May 1, 2023. A summary of key points are as follows:
For more information, Please visit:
Revisions to the Enforcement Rules of the Patent Act Shall be Enacted on May 1, 2023
TIPO has updated the Taiwan-Japan Concordance of Similar Group Codes (corresponding to NCL12-2023) according to WIPO’s latest revisions to the Nice Classification, 12th Edition-Version 2023. Applicants are welcome to refer to the document when registering a trademark.
For more information, Please visit:
TIPO Publishes Taiwan-Japan Concordance of Similar Group Codes (corresponding to NCL12-2023)
台湾特許出願
特許等明細書の翻訳文献翻訳
出願前・審査請求時に行う調査
意見書・手続補正書の作成
料金納付 - 設定登録
料金納付 - 年金納付
その他審判事件(無効・訂正)
遠 碩 專 利 師 事 務 所 | |
Lewis & Davis Patent Attorneys Office | 12 Fl. No. 290, Fuxing N. Rd. Taipei 10478, Taiwan |
TEL:+886-2-2517-5955 FAX:+886-2-2517-8517 | E-mail:このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。 |